Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses

Last updated: August 19, 2022
Sponsor: University of Regensburg
Overall Status: Active - Recruiting

Phase

N/A

Condition

Malignant Ascites

Peritoneal Cancer

Digestive System Neoplasms

Treatment

N/A

Clinical Study ID

NCT04108936
15-101-0357
  • Ages 18-80
  • All Genders

Study Summary

Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • suspicious peritoneal carcinomatosis

Exclusion

Exclusion Criteria:

  • <18 years

Study Design

Total Participants: 250
Study Start date:
October 01, 2016
Estimated Completion Date:
July 31, 2028

Study Description

Cross-sectional and longitudinal analysis of cellular immune responses in the context of disease outcome.

Cross-sectional and longitudinal analysis of the microbiome in the context of disease outcome.

Analysis of renal function with respect of different HIPEC regimens

Identification of clinical surrogate parameters for outcome.

Connect with a study center

  • Krankenhaus der Barmherzigen Brüder Regensburg

    Regensburg, Bavaria 93049
    Germany

    Site Not Available

  • University Hospital Regensburg

    Regensburg, 93053
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.